Target Name: FGA
NCBI ID: G2243
Review Report on FGA Target / Biomarker Content of Review Report on FGA Target / Biomarker
FGA
Other Name(s): MGC119423 | Fibrinogen alpha chain | Fibrinogen alpha chain, transcript variant alpha-E | FGA variant alpha | Guanine nucleotide exchange factor VAV3 (isoform 1) | FIBA_HUMAN | fibrinogen, A alpha polypeptide | fibrinogen alpha chain | Guanine nucleotide exchange factor VAV3 | Fibrinogen alpha chain (isoform alpha) | Fibrinopeptide A | Fibrinogen alpha chain, transcript variant alpha | vav 3 oncogene | vav 3 guanine nucleotide exchange factor | MGC119422 | VAV-3 | VAV3 | VAV3_HUMAN | FGA variant alpha-E | Fibrinogen, alpha chain, isoform alpha preproprotein | MGC119425 | Fibrinogen alpha chain (isoform alpha-E) | Fib2 | Fibrinogen, A alpha polypeptide

FGA: A Tool for Genomics Research and Drug Discovery

FGA, short for Fused Genomic Alignment, is a computational tool that has been widely used in the field of genomics. It is used for the analysis of genomic data, including DNA sequencing and microarray data, to identify genomic regions that contain specific genetic or expression patterns.

One of the applications of FGA is the identification of potential drug targets. By analyzing a patient's genetic data, healthcare professionals can identify the genetic variants or expression changes that are associated with the disease and develop targeted treatments. This approach has the potential to improve the accuracy and effectiveness of personalized medicine.

FGA can also be used as a biomarker to diagnose and monitor diseases. For example, it can be used to diagnose genetic disorders by identifying the specific genetic changes that are associated with a particular disease. It can also be used to monitor the effectiveness of treatments by analyzing the levels of specific genes or genetic variants that are associated with the disease.

In addition to its use in drug discovery and disease diagnosis, FGA has also has potential applications in the fields of research and development. It can be used to analyze large genomic datasets and identify patterns that may be relevant to a particular research question. It can be used to analyze large genomic datasets and identify patterns that may be relevant to a particular research question. also be used to predict the outcomes of experiments, such as the response of cancer cells to different treatments.

FGA has the potential to revolutionize the field of genomics by making it possible to analyze large datasets more quickly and accurately than ever before. It can also help identify new drug targets and monitor the effectiveness of treatments in real-time. However, it is important to note that FGA is still a relatively new technology and more research is needed to fully understand its potential applications.

In conclusion, FGA has the potential to be a valuable tool for drug discovery, disease diagnosis, and research. Its ability to analyze large genomic datasets and identify specific genetic or expression patterns makes it an attractive tool for identifying potential drug targets and monitoring the effectiveness of treatments. As the field of genomics continues to evolve, it is likely that we will see even more innovative applications for FGA in the future.

Protein Name: Fibrinogen Alpha Chain

Functions: Cleaved by the protease thrombin to yield monomers which, together with fibrinogen beta (FGB) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However, subsequent studies have shown that it is not absolutely required for thrombus formation in vivo. Enhances expression of SELP in activated platelets via an ITGB3-dependent pathway. Maternal fibrinogen is essential for successful pregnancy. Fibrin deposition is also associated with infection, where it protects against IFNG-mediated hemorrhage. May also facilitate the immune response via both innate and T-cell mediated pathways

The "FGA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FGA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FGB | FGD1 | FGD2 | FGD3 | FGD4 | FGD5 | FGD5-AS1 | FGD5P1 | FGD6 | FGF1 | FGF10 | FGF10-AS1 | FGF11 | FGF12 | FGF12-AS2 | FGF13 | FGF13-AS1 | FGF14 | FGF14-AS1 | FGF14-AS2 | FGF14-IT1 | FGF16 | FGF17 | FGF18 | FGF19 | FGF2 | FGF20 | FGF21 | FGF22 | FGF23 | FGF3 | FGF4 | FGF5 | FGF6 | FGF7 | FGF7P3 | FGF7P5 | FGF7P6 | FGF8 | FGF9 | FGFBP1 | FGFBP2 | FGFBP3 | FGFR1 | FGFR1OP2 | FGFR2 | FGFR3 | FGFR3P1 | FGFR4 | FGFRL1 | FGG | FGGY | FGL1 | FGL2 | FGR | FH | FHAD1 | FHDC1 | FHF Complex | FHIP1A | FHIP1B | FHIP2A | FHIP2B | FHIT | FHL1 | FHL2 | FHL3 | FHL5 | FHOD1 | FHOD3 | FIBCD1 | FIBIN | FIBP | Fibrinogen | Fibroblast growth factor (FGF) | Fibroblast Growth Factor Receptor (FGFR) | Fibronectin Type III Domain | FICD | FIG4 | FIGLA | FIGN | FIGNL1 | FIGNL2 | FILIP1 | FILIP1L | FILNC1 | FIP1L1 | FIRRE | FIS1 | FITM1 | FITM2 | Five friends of methylated CHTOP complex | FIZ1 | FJX1 | FKBP10 | FKBP11 | FKBP14 | FKBP15 | FKBP1A | FKBP1A-SDCBP2